Please mail comments on any article to ddil@episun1.harvard.edu. A digest of readers' comments will be appended to each article.
Updated June 12, 1999
Drugs
Removed from the Market or Receiving Black Box Warnings in the United States
1997-1997 and Matched Drugs with Uneventful Safety Histories: Narrative
Description, by Jennifer I. Kuesters, Linda J. Lawrie, Rebecca S. Wells,
and Alexander M. Walker (6/8/99)
Chelation
Therapy for Childhood Lead Poisoning: Does Excretion Equal Efficacy ?,
by Adrienne S. Ettinger (4/23/99)
Selective
Serotonin Reuptake Inhibitors And Sexual Dysfunction: A Historical Review
Of The Development Of Evidence For An Adverse Effect, by Anita K. Wagner
(4/14/99)
Nonsteroidal
anti-inflammatory drugs and blood pressure, by Chen-Chang Yang (4/14/99)
Should Phen-Pro
Replace Phen-fen?, by Candice Silversides and Sara Cherkerzian (10/21/98)
KETOROLAC
AND GASTROINTESTINAL TOXICITY: A perspective from 1998, by Francisco
J. De Abajo (6/9/98)
Alexander M. Walker reviews the history
of Aminorex (12/2/97)
Pertussis Vaccination
and Serious Central Nervous System Disorders: Early Case Series Evidence
and Public Reaction, by Margaret Ann Goetz. (8/7/97)
Drug-Induced
Parkinsonism: Are Cinnarizine and Flunarizine Implicated?, by Guilherme
L. Werneck. (7/7/97)
The Influenza
A/New Jersey (Swine Flu) Vaccine and Guillain-Barré Syndrome: the
arguments for a causal association, by Elissa A. Laitin and Elise M.
Pelletier. (6/20/97)
Serevent
and increased morbidity and mortality from asthma: a historical review
of the evidence, by Steve Duff. (6/18/97)
The relationship
between benzodiazepines and hip fracture in the elderly, by Eileen
Ming. (6/18/97)
Adverse
effects of botanical and non-botanical ephedrine products, by June
Weintraub. (6/18/97)
The
relationship between stimulants and tic disorders in children treated for
Attention Deficit Hyperactivity Disorder, by Eric Mick. (6/18/97)
Vera Mastey provides a historical
review of Torsades
de Pointes in Patients Receiving Terfenadine or Astemizole. (8/23/95)
James Hegarty describes the evolution
of a controversy over whether Prozac could cause violence in Suicidal
and violent behavior associated with the use of fluoxetine. (6/22/95)
Alexander M. Walker discusses when
data must be regarded as "personally identified," in Generic
Data. (4/18/95)
Philip S. Wang reviews the carcinogenicity
of antidepressants in The
Epidemiology of Depression and Cancer: Do Antidepressant Medications Play
a Role? (4/18/95)
Return to the DDIL Homepage
This document has been provided through the Drugs and Devices Information Line, http://www.hsph.harvard.edu/Organizations/DDIL/ddil.html
If you have questions or comments about the DDIL, please write to: ddil@episun1.harvard.edu